Revenue came in at $17.7 billion, an increase of 31% year over year, which is beyond excellent for a pharmaceutical giant.

In an August 2024 report, J.P. Morgan analysts revealed that there's a 35% chance the U.S. will fall into a recession by the ...

stock as well. And this wasn't Bloom's only good news. While sales shrank 18.5% year over year, Bloom succeeded in shrinking ...

Stocks closed at record highs on Friday, with the S&P 500, Dow Jones, and Nasdaq 100 all notching their biggest weekly gain ...

Tax policy changes post-election could trigger significant market moves, depending on the political landscape. Click here to ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...

The stock of coatings and paint supplier Sherwin-Williams (NYSE: SHW) popped Monday morning after news about the company was released late Friday. Shares jumped as much as 7% before paring some of ...

The polls are open, and investors are in wait-and-see mode to find out whether Harris or Trump will win — and how long it'll take to get a clear outcome.

Also know that, unlike the S&P 500 or the Nasdaq Composite, the Dow is weighted by price rather than by market cap. Although ...

Investors are bracing for a long night amid the contentious U.S. presidential race that will have big ramifications for the ...

Cards' James Conner Ranks No. 6 in NFL in Rushing; Davante Adams & Aaron Rodgers a TD Shy of Ben Roethlisberger & Antonio Brown ...

Hims & Hers Health (NYSE: HIMS) reported another blowout quarter recently, but the stock didn't get the type of pop that ...